If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

29 Jul 2025 17:10

RNS Number : 0649T
Compagnie de Saint-Gobain
29 July 2025
 

SAINT-GOBAIN reinforcES ITS construction chemicals platform WITH three bolt-on ACQUISITIONsin North america, Italy and peru

 

 

Saint-Gobain reinforces its construction chemicals platform with:

 

· Two acquisitions securing key technologies that it will scale across the Group, Interstar Materials in North America and Isoltech in Italy;

 

· A local acquisition in Peru, Soquimic, enhancing Saint-Gobain's footprint in this high-growth market.

 

Interstar Materials is a leading North American manufacturer of high-performance pigments for all segments of concrete including ready-mix and precast concrete. Established in 1987, it operates two facilities in Canada (Quebec and Alberta) and one in the United States (Illinois). Concrete coloring has become popular amongst architects and contractors, with granular pigments having many advantages over liquid or powder pigments: they yield more vibrant colors, are simple to transport and store, easy to handle without temperature constraints and more environmentally friendly. Interstar will enrich Saint-Gobain's range of solutions for the growing demand in decorative concrete solutions for façade, flooring and architectural elements and benefit from the Group's strong presence in construction chemicals in North America.

 

Isoltech is an Italian manufacturer of additives specialized in cellular concrete technology used in the production of lightweight concrete. Established in 1987, it operates a production facility in Verdellino, northern Italy. Its solutions are widely recognized for their excellent thermal and acoustic insulation, as well as their fire resistance, recyclability, vapor and water permeability. Isoltech serves the ready-mix concrete, precast and screed markets.

 

Soquimic is a leading manufacturer of concrete admixtures in Peru. Established in 2013, the company has two plants located in Lurin, near Lima, and in Arequipa, in southern Peru. This transaction will enrich Saint-Gobain's range of solutions and accelerate its growth in Peru, following the acquisition of Z Aditivos in 2021, offering cement additives, and will complement the offering of Weber tile adhesives and facade renders.

 

Interstar, Isoltech and Soquimic generate revenues of around €25 million. They will benefit from Chryso's expertise, innovation and R&D capabilities to support customers in the development of low-carbon materials and from Saint-Gobain's global geographical footprint to expand their portfolio and value proposition in the market.

 

These acquisitions are in line with Saint-Gobain's strategic plan, "Grow & Impact" which aims to both strengthen the Group's worldwide leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Alix Sicaud:

+33 1 88 54 38 70

Yanice Biyogo: 

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRLMFTMTMTBAA
Date   Source Headline
5th Sep 20088:03 amRNSIssue of Debt
24th Jul 20086:06 pmRNSInterim Results
15th Jul 200810:07 amRNSOffer Update
4th Jul 20089:08 amRNSDirectorate Change
3rd Jul 20081:29 pmRNSCancellation and De-listing
1st Jul 20087:00 amRNSOffer Update
23rd Jun 20085:19 pmRNSNew plant in India
20th Jun 20087:13 amRNSOffer Update
10th Jun 20087:00 amRNSOffer Update
6th Jun 20088:05 amRNSAcquisition
6th Jun 20088:04 amRNSAGM Statement
29th May 20084:18 pmRNSNotice of EGM
29th May 200810:16 amRNSProduct Launch
20th May 20088:01 amRNSOffer Document Posted
7th May 20084:59 pmRNSOffer for Gibbs & Dandy PLC
22nd Apr 20085:12 pmRNS1st Quarter Results
25th Mar 20087:00 amRNSRe Agreement
25th Mar 20087:00 amRNSAcquisition
25th Mar 20087:00 amRNSFinal Results
17th Mar 20087:00 amRNSAcquisition
25th Jan 20084:22 pmRNSAnnual Report and Accounts
21st Dec 20078:51 amRNSAcquisition
26th Nov 20075:12 pmRNSRe Joint Venture
8th Nov 20075:10 pmRNSAcquisition
2nd Nov 20078:49 amRNSDisposal
24th Oct 20077:00 amRNS3rd Quarter Results
7th Aug 20077:46 amRNSAcquisition
27th Jul 20075:20 pmRNSDisposal
27th Jul 20077:00 amRNSInterim Results
18th Jul 20077:30 amRNSAcquisition
17th Jul 200712:53 pmRNSDisposal
26th Apr 20075:20 pmRNS1st Quarter Results
23rd Apr 20078:23 amRNSRe Joint Venture
11th Apr 20076:01 pmRNSAcquisition
28th Mar 20078:40 amRNSIssue of Debt
23rd Mar 20076:00 pmRNSFinal Results
21st Feb 20077:46 amRNSRe Joint Venture
19th Feb 20075:43 pmRNSNew Plant
13th Feb 20078:00 amRNSAcquisition
26th Jan 20073:53 pmRNSInterim Results
21st Dec 20065:12 pmRNSAdditional Listing
3rd Nov 20068:53 amRNSIssue of Debt
24th Oct 20065:17 pmRNS3rd Quarter Results
6th Sep 20068:08 amRNSAcquisition
6th Sep 20068:05 amRNSAcquisition
28th Jul 200612:10 pmRNSInterim Results
28th Jul 200612:04 pmRNSRe Alliance
25th May 200612:28 pmRNSStabilisation Notice
25th May 200612:26 pmRNSStabilisation Notice
24th May 20063:24 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.